Found 5 matching trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial studies how well trametinib and Akt inhibitor GSK214179...
Show More Location
Foothills Hospital
Learn More & Join Trial
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer PHASE1 This phase I/II trial studies the side effects and the best dose of uproser...
Show More Location
USC / Norris Comprehensive Cancer Center
Learn More & Join Trial
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma PHASE2 This randomized phase II trial studies how well trametinib with or without ...
Show More Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Learn More & Join Trial
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer PHASE1 This randomized phase I trial studies how well trametinib with or without G...
Show More Location
Hartford Hospital
Learn More & Join Trial
Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 N/A This trial assesses blood and tumor samples for the effect of trametinib wi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial